
Endoglin (CD105) is a type III auxiliary receptor for the transforming growth factor beta (TGFβ) superfamily. Several lines of evidence suggest that endoglin plays a critical role in maintaining cardiovascular homeostasis. Seemingly disparate disease conditions, including hereditary hemorrhagic telangiectasia, pre-eclampsia, and cardiac fibrosis, have now been associated with endoglin. Given the central role of the TGFβ superfamily in multiple disease conditions, this review provides a detailed update on endoglin as an evolving therapeutic target in the management of cardiovascular disease.
Male, Ventricular Remodeling, Endoglin, Receptors, Cell Surface, Review, Ligands, Cardiovascular System, Vascular Health and Risk Management, Pre-Eclampsia, Antigens, CD, Cardiovascular Diseases, Pregnancy, Transforming Growth Factor beta, Animals, Homeostasis, Humans, Female, Telangiectasia, Hereditary Hemorrhagic, Signal Transduction
Male, Ventricular Remodeling, Endoglin, Receptors, Cell Surface, Review, Ligands, Cardiovascular System, Vascular Health and Risk Management, Pre-Eclampsia, Antigens, CD, Cardiovascular Diseases, Pregnancy, Transforming Growth Factor beta, Animals, Homeostasis, Humans, Female, Telangiectasia, Hereditary Hemorrhagic, Signal Transduction
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 45 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
